Study Suggests Potential of New Therapy for Progressive Multiple Sclerosis
September 05, 2018
September 05, 2018
PORTLAND, Oregon, Sept. 5 -- Oregon Health and Science University issued the following news release:
A new clinical trial, published in The New England Journal of Medicine, offers hope for patients who suffer from progressive multiple sclerosis.
Results from the phase 2 clinical trial suggest the medication ibudilast potentially could be among the first effective therapies for primary and secondary progressive MS. The study found that brain atrophy was slowed considerab . . .
A new clinical trial, published in The New England Journal of Medicine, offers hope for patients who suffer from progressive multiple sclerosis.
Results from the phase 2 clinical trial suggest the medication ibudilast potentially could be among the first effective therapies for primary and secondary progressive MS. The study found that brain atrophy was slowed considerab . . .